youtube_live
Q2 2027 earnings • 5:30 AM tomorrow
See detailschevron_right
UPL:NSE
UPL Ltd
₹513.35
arrow_downward
-5.28%(-28.60) 1D
Oct 30, 3:30:00 PM GMT+5:30 · INR
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for UPL...
Open
₹540.00
High
₹541.95
Low
₹512.80
Mkt. cap
466.46B
Avg. vol.
2.30M
Volume
2.31M
Dividend
1.17%
Quarterly dividend
₹1.50
Ex-dividend date
Jul 17, 2026
P/E ratio
20.69
52-wk high
₹812.20
52-wk low
₹476.45
EPS
₹24.81
Shares outstanding
0.00
No. of employees
12K
Open
₹540.00
High
₹541.95
Low
₹512.80
Mkt. cap
466.46B
Avg. vol.
2.30M
Volume
2.31M
Dividend
1.17%
Quarterly dividend
₹1.50
Ex-dividend date
Jul 17, 2026
P/E ratio
20.69
52-wk high
₹812.20
52-wk low
₹476.45
EPS
₹24.81
Shares outstanding
0.00
No. of employees
12K
News stories
From web sources and news partners
Seeking Alpha
·
18 minutes ago
QQQM: The Nasdaq 100 Is Having A Panic Attack And I Think This Pullback Should Be Bought
Yahoo Finance
·
1 hour ago
Why Is ASML Holding (NasdaqGS:ASML) Tying Executive Pay To Employee Morale?
The Globe and Mail
·
1 hour ago
A Wall Street Firm Modeled Out an AI Crash: S&P 500 Down 30%, $20 Trillion Gone. But Here's What Happens Next
CNBC
·
1 day ago
Anthropic's path to the Nasdaq just got a lot bumpier
Profile
UPL Limited, formerly United Phosphorus Limited, is an Indian multinational company that manufactures and markets agrochemicals, industrial chemicals, chemical intermediates, and specialty chemicals. Headquartered in Mumbai, the company is primarily engaged in the manufacture and marketing of conventional agrochemicals, seeds, and other agriculture-related products. It also manufactures fungicides, herbicides, insecticides, plant growth regulators, rodenticides, industrial and specialty chemicals, and nutrifeeds.
United Phosphorus Limited was established on 29 May 1969. The company changed its name to UPL Limited in October 2013.
On 20 July 2018, UPL signed a US$4.2 billion agreement with Platform Specialty Products Corporation to acquire control of Arysta LifeScience Inc. The acquisition was completed in February 2019, making UPL the fifth largest generic agrochemicals company in the world after Bayer, Corteva, Syngenta and BASF. Wikipedia
About UPL Ltd
CEOJaidev Rajnikant Shroff
Employees12.4K
Founded1969
HeadquartersBandra West, Maharashtra, India
SectorFertilizer
Websiteupl-ltd.com
Next call in 16:15:44
Tomorrow, 5:30 AM
Fiscal period
Q2 2027
- Normalized EPS / Est. (INR)
- GAAP EPS / Est. (INR)
- / ₹4.72
Revenue / Est. (INR)
- / 116.56B
Fiscal Q2 2027 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in INR | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 120.19B | 122.69B | 183.35B | 101.81B |
Cost of goods sold | 57.53B | 58.46B | 105.17B | 43.15B |
Cost of revenue | 57.53B | 58.46B | 105.17B | 43.15B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 14.66B | 13.79B | 24.76B | 15.27B |
Operating expense | 48.32B | 48.17B | 50.77B | 51.98B |
Total operating expenses | 105.85B | 106.63B | 155.94B | 95.13B |
Operating income | 14.34B | 16.06B | 27.41B | 6.68B |
Other non operating income | 2.50B | 920.00M | -6.04B | 2.17B |
EBT including unusual items | 7.84B | 6.71B | 18.92B | -1.09B |
EBT excluding unusual items | 6.42B | 7.27B | 18.81B | -1.00B |
Income tax expense | 1.72B | 1.81B | 5.98B | -360.00M |
Effective tax rate | 21.94% | 26.97% | 31.61% | 33.03% |
Other operating expenses | 24.81B | 25.46B | 13.07B | 27.33B |
Net income | 5.53B | 3.96B | 10.61B | 100.00M |
Net profit margin | 4.60% | 3.23% | 5.79% | 0.10% |
Earnings per share | 8.09 | 4.87 | 12.70 | 0.19 |
Interest and investment income | - | - | 5.26B | - |
Interest expense | -7.53B | -7.00B | -6.64B | -7.59B |
Net interest expenses | -7.53B | -7.00B | -1.38B | -7.59B |
Depreciation and amortization charges | 7.71B | 8.27B | 9.15B | 8.32B |
EBITDA | 21.85B | 19.14B | 31.10B | 10.37B |
Gain or loss from assets sale | - | - | - | - |
Upcoming events